Hypertension control in Kerala, India: a prescription-based study

Written By :  Dr. Nandita Mohan
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-06-17 04:30 GMT   |   Update On 2022-06-17 09:21 GMT

A prescription-based study was conducted to identify the provider and institution-level factors related to achieving guideline-recommended control of hypertension and diabetes mellitus in the state of Kerala.The cross-sectional study in primary and secondary care hospitals in Kerala included both public and private institutions. One practitioner was selected from each institution....

Login or Register to read the full article

A prescription-based study was conducted to identify the provider and institution-level factors related to achieving guideline-recommended control of hypertension and diabetes mellitus in the state of Kerala.

The cross-sectional study in primary and secondary care hospitals in Kerala included both public and private institutions. One practitioner was selected from each institution. Prescriptions were photographically captured and data on disease status and drugs prescribed were recorded. Totally 4679 prescriptions were included for analysis.

For hypertension-only patients, control levels were 31.5% and was significantly higher in public hospitals.

Among patients with diabetes only, diabetes control was seen in 36.6%. When both conditions were present, control was achieved in only 17.0% patients.

Being prescribed two or more drugs indicated lower control.

Hence,In this prescription-based study in Kerala, a majority of hypertensive patients did not have controlled blood pressure levels, particularly if diabetes coexisted. This has serious implication as Kerala is the state with the highest burden of hypertension in India.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News